Corona in general

People who have had Covid-19 are at increased risk of developing type 2 diabetes. This is the result of a study by DDZ, DZD and IQVIA, which has now been published in Diabetologia. // // 21.3.2022

Researchers discuss the difference between transmitters and non-transmitters of SARS-CoV-2 in terms of their mean viral load. // 21.3.2022

Researchers illustrated that vitamin D status and age influence antibody response following the initial dose of coronavirus disease 2019 vaccination. // 21.3.2022

Researchers demonstrated the role of integrin signaling in vascular dysfunction associated with SARS-CoV-2 infection. // 21.3.2022

We studied the relationship between declines in mobility and subsequently reported COVID-19 case incidence in 111 of the most populous U.S. counties during the Omicron surge from December 2021 through February 2022. // 18.3.2022

Patients infected with the Omicron variant of SARS-CoV-2 remain contagious for just as long as patients infected with earlier variants, according to a small study. // 18.3.2022

Objective To study the association between covid-19 vaccines, SARS-CoV-2 infection, and risk of immune mediated neurological events. // 27.1.2022

Huddersfield researchers were among the first to demonstrate how the induction of brain inflammation accounts for neurological damage in COVID19 patients and now, their findings have been published in a peer-reviewed medical journal. // 17.3.2022

Researchers identified independent factors associated with early and late deaths in hospitalized COVID-19 patients. // 17.3.2022

Researchers established the impact of SARS-CoV-2 infection on glycated hemoglobin levels, type 2 diabetes risk, and diabetic ketoacidosis through data from the large real-world clinical cohort. // 17.3.2022

Researchers investigate if a decline in exercise capabilities is due to deconditioning during infection or long-term reductions in ability due to COVID-19. // 15.3.2022

Introduction. Shared characteristics between COVID-19 and pulmonary fibrosis, including symptoms, genetic architecture, and circulating biomarkers, suggests interstitial lung disease (ILD) development may be associated with SARS-CoV-2 infection. // 12.3.2022

Researchers observed that Golgi fragmentation induced by SARS-CoV-2 facilitates viral trafficking. // 11.3.2022

The relationship between transmission of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) and the amount of virus present in the proximity of a susceptible host is not understood. Here, we developed a within-host and aerosol mathematical model and used it to determine the relationship between viral kinetics in the upper respiratory track, viral kinetics in the aerosols, and new transmissions in golden hamsters challenged with SARS-CoV-2. // 9.3.2022

A recent study by US researchers shows how the performance of rapid antigen tests to diagnose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not inferior among individuals infected with the Omicron variant compared to the Delta variant. // 7.3.2022

In a recent study posted to the medRxiv* preprint server, researchers identified that morning-collected nasal and saliva samples yielded better detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially in tests with low to moderate analytical sensitivity. // 8.3.2022

A recent study reported that monocytosis during the acute phase of coronavirus disease 2019 could forecast anosognosia in long COVID. // 8.3.2022

Scientific Reports - ACE2 protein expression in lung tissues of severe COVID-19 infection // 8.3.2022

Scientific Reports - Reduced levels of pulmonary surfactant in COVID-19 ARDS // 8.3.2022

COVID-19 is likely to increase the risk for pulmonary aspergillosis and mucormycosis, life-threatening infections caused by environmental molds. // 3.3.2022

The updated guidance does not recommend specific wait times for vaccinated patients, instead saying providers should use their clinical judgement. // 28.2.2022

A new study published in the journal Diagnostics provided an overview of ROTEM with a particular focus on interpreting the symmetrical clot formation curve. Researchers also introduced new parameters that could aid in distinguishing between COVID-19 patients and outcomes. // 28.2.2022

Nature - Report authors say that the coronavirus SARS-CoV-2 jumped from animals sold at the market into people twice in late 2019 — but some scientists want more definitive evidence. // 27.2.2022

Two new studies say the virus was present in animals at the Huanan seafood market in 2019. // 26.2.2022

A new study discusses the possible role of melatonin, an antioxidant and anti-inflammatory agent, in treating COVID-19. // 24.2.2022

Researchers demonstrated that the SARS-CoV-2 viroporins precipitate cytokine storm via the alteration of mitochondrial physiology in severe COVID-19. // 24.2.2022

In a new study, researchers studied SARS-CoV-2 infection on the transcription of mitochondrial oxidative phosphorylation, glycolysis, nutrient sensing, and stress response genes. // 24.2.2022

New study findings showed that SARS-CoV-2 caused a productive yet restricted infection of pancreatic islet cells and an insignificant inflammatory response. // 23.2.2022

In a recent study posted to the medRxiv* preprint server, researchers characterized the mechanisms associated with neural dysregulation in post-coronavirus disease (COVID) fatigue (pCF) by evaluating individuals recovered from mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. // 23.2.2022

A recent study investigates samples solated from unexposed individuals pre-pandemic to determine the presence of pre-existing SARS-CoV-2 B-cell immunity. // 22.2.2022